EQUITASBNK vs SUNPHARMA: Stock Comparison
Head-to-head financial and trading comparison between Equitas Small Finance Bank Limited (EQUITASBNK) and Sun Pharmaceutical Industries Limited (SUNPHARMA) in the Cross-Sector Peers sector.
EQUITASBNK
NSE: EQUITASBNKSUNPHARMA
NSE: SUNPHARMAKey Metrics Comparison Table
| Metric | EQUITASBNK | SUNPHARMA | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹66.02 | ₹1,760.00 | — |
| 1-Year Price Return | +3.29% | +5.48% | SUNPHARMA (2.19% higher) |
| 52-Week High | ₹83.07 | ₹2,001.10 | — |
| 52-Week Low | ₹63.92 | ₹1,620.40 | — |
| 30-Day Annualized Volatility | 27.7% | 20.49% | SUNPHARMA (Steadier) |
| 30-Day Average Daily Volume | 1,696,172 | 1,603,895 | EQUITASBNK (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between EQUITASBNK and SUNPHARMA, which stock gave better returns over the last year?
SUNPHARMA has outperformed EQUITASBNK over the past 12 months with a gain of 5.48% compared to 3.29%.
Which stock is less volatile: EQUITASBNK or SUNPHARMA?
SUNPHARMA demonstrated lower price volatility (20.49% annualized) compared to EQUITASBNK (27.7%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of EQUITASBNK vs SUNPHARMA?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are EQUITASBNK and SUNPHARMA direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.